The Shaz Lounge

[PennyStock Alert]

ARYC MUST READ DD:

Silicon Valley biotech stock Arrayit Corporation (OTC: ARYC) Due Diligence link:

https://cdn.discordapp.com/attachments/357369664193560596/459932549062590475/Arrayit_Due_Diligence_Report_.pdf


ARYC chart:
http://stockcharts.com/h-sc/ui?s=Aryc


Arrayit Store sales exceed $55,000,000 all time on 230,706 products and services sold since on-line inception shop.arrayit.com https://twitter.com/i/web/status/895347576010031104


If you live near Silicon Valley, you can visit the company at:

Arrayit Corporation
927 Thompson Place
Sunnyvale, CA 94085
USA
Phone [phone]

Located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry.


Recent Press Release:

Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains
Print
Alert
Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has completed an allergy testing pilot program for one of nation’s largest chains of retail stores. The retailer collected finger stick blood specimens from 126 customers at their in-store clinics, and shipped the blood cards to Arrayit for processing. Arrayit processed the specimens and reported 126 quantitative total immunoglobulin E (IgE) measurements and 15,120 allergen-specific determinations indicative of food and environmental allergies. The test results were reviewed and approved by the retail chain’s Chief Medical Officer.

Arrayit allergy testing is particularly suitable for large retail chains because convenient finger stick sampling allows customers to integrate a physician-ordered allergy test into their real-time shopping experience. The test results, together with patient symptoms and medical history, enable in-store doctors to make personalized medical recommendations about allergy and asthma treatments and medicines, which are also conveniently provided by the retailer. The retail chain, which reports revenues exceeding $50,000,000,000 ($50 billion US dollars) annually, has more than 2,000 locations nationwide.

Arrayit CEO Rene Schena states, “Completing an allergy testing pilot program for a major retailer advances our clinical initiatives. Arrayit personalized allergy testing, in the context of 1,700 sales reps and a large retail chain, would accelerate our mission to provide health and wellness information to millions of American households.”

https://www.yahoo.com/amphtml/finance/news/arrayit-corporation-completes-allergy-testing-093000485.html


Recent company Tweets:

Arrayit signs capital financing agreement with a top buy-side analyst at a leading corporate intelligence firm headquartered in London UK with offices in New York and providing buy-side intelligence to high net worth retail investors, institutional investors and hedge funds.

Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.

Arrayit senior management receives NASDAQ and NYSE up-listing proposal from small and mid-cap consulting experts http://uplisting.com focusing on growth companies seeking to improve and enhance shareholder value by listing on a major stock exchange http://www.uplisting.com

http://arrayit.com/